ciprofloxacin 50 MG/ML Oral Suspension [Cipro]
ciprofloxacin
RxCUI: 213224
What the CMS Formulary Data Shows for ciprofloxacin 50 MG/ML Oral Suspension [Cipro]
Per the CMS 2026 Part D formulary file, ciprofloxacin 50 MG/ML Oral Suspension [Cipro] (RxNorm concept RXCUI 213224, generic name ciprofloxacin) appears on 2 distinct formulary files spanning 3 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.
Real-world access to ciprofloxacin 50 MG/ML Oral Suspension [Cipro] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,810 Part D beneficiaries filled ciprofloxacin 50 MG/ML Oral Suspension [Cipro] in 2023, with total plan-and-beneficiary spending of $396,416 and an average per-beneficiary annual cost of $219.01. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ciprofloxacin 50 MG/ML Oral Suspension [Cipro] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 3
- Coverage rate
- 0.1%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,810
- Total spending
- $396,416
- Avg per beneficiary
- $219.01
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ciprofloxacin 50 MG/ML Oral Suspension [Cipro]
3 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
| Samaritan Dual Advantage (HMO D-SNP) | SAMARITAN HEALTH PLANS, INC. | T4 | No | $10.50 | OR |
Frequently Asked Questions
Is ciprofloxacin 50 MG/ML Oral Suspension [Cipro] covered by Medicare Part D?
Yes, ciprofloxacin 50 MG/ML Oral Suspension [Cipro] is covered by 3 Medicare Part D plans (0.1% of all Part D formularies).
What tier is ciprofloxacin 50 MG/ML Oral Suspension [Cipro] on Medicare Part D plans?
ciprofloxacin 50 MG/ML Oral Suspension [Cipro] averages Tier 2.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does ciprofloxacin 50 MG/ML Oral Suspension [Cipro] require prior authorization?
0% of Part D formularies require prior authorization for ciprofloxacin 50 MG/ML Oral Suspension [Cipro]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on ciprofloxacin 50 MG/ML Oral Suspension [Cipro]?
In 2023, total Medicare Part D spending on ciprofloxacin 50 MG/ML Oral Suspension [Cipro] was $396,416, covering 1,810 beneficiaries. The average spend per beneficiary was $219.01.
Read our methodology - how this data is sourced, computed, and verified.